Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Recruiting2
Other1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT06000787Not ApplicableRecruiting
MCT for the Harvard/UCSF ROBIN Center
Glioma, Childhood BrainstemNeuroblastoma
PrincipalinvestigatorStart date: 2023-09-19
NCT04393948Not ApplicableWithdrawn
Lung Irradiation for COVID-19 Pneumonia
SARS-CoV 2
PrincipalinvestigatorStart date: 2020-06-19
NCT04242095Recruiting
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell NeoplasmImmune System DisorderMalignant Solid Neoplasm
StudychairStart date: 2020-03-12

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Lorenzo Cohen

M.D. Anderson Cancer Center

Related
10 trials

Shared therapeutic areas:

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Neuroblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Gail Gauvreau, PhD

McMaster University

Related
12 trials

Shared therapeutic areas:

Immune System Diseases
Similarity Score5%

Partow Kebriaei, MD

M.D. Anderson Cancer Center

Related
10 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

SARS-CoV 2
Similarity Score5%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Neuroblastoma
Similarity Score5%

David Hui, MD

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Brian Kushner, MD

Memorial Sloan Kettering Cancer Center

Related
12 trials

Shared therapeutic areas:

Neuroblastoma
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06000787Not ApplicablePrincipalInvestigator

MCT for the Harvard/UCSF ROBIN Center

Glioma, Childhood BrainstemNeuroblastoma
Recruiting
NCT04393948Not ApplicablePrincipalInvestigator

Lung Irradiation for COVID-19 Pneumonia

SARS-CoV 2
Withdrawn
NCT04242095StudyChair

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Hematopoietic and Lymphoid Cell NeoplasmImmune System DisorderMalignant Solid Neoplasm
Recruiting

All 3 trials loaded